To summarize experimental and clinical evidence on the association between tumor necrosis factor-α (TNF-α) and nonalcoholic fatty liver disease (NAFLD) and discuss potential treatment considerations. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.